The ọgwụ 'Atọ-regolith'. ntụziaka Description

Otu Nchikota gbochie afọ bụ ọgwụ "Atọ-regolith". The mejupụtara mejupụtara na Nchikota na ethinyl estradiol levonorgestrel. Dị ka ọ pụtara ìhè site nzaghachi nke ọtụtụ ndị ọrịa, ọgwụ bụ nnọọ irè na-ọma na-anabata.

Na-akọwa usoro nke ihe nke ego "Atọ-regolith", ntụziaka na-egosi ike nke nọ n'ọrụ ogige nke ibelata mmepụta nke pituitary gonadotropins. Levonorgestrel na-eji dị ka progestin akụrụngwa, na-eme na-anabata ya enweghị n'ịnwụ mbido metabolic mgbanwe. Estrogenic compound bụ ethinyl estradiol na ọgwụ.

N'ihi mmetụta nke levonorgestrel egbochi ntọhapụ nke FSH na LH hypothalamic mgbochi emee emepụta gonadotropins. Nke a na n'aka slows ala ovulation.

Ethinyl estradiol enhances ogwu mmetụta. N'okpuru nduzi nke a akụrụngwa bụ a elu viscosity nke imi na cervix, nke ukwuu na-egbochi ndị penetration nke spam n'ime eriri akpa nwa oghere.

Ọgwụ "Atọ-regolith" (ntuziaka na-egosi nke a) na mgbe nile were na-enyere aka normalize na ịhụ nsọ okirikiri. Ọgwụ gbochie omume nke ụfọdụ gynecological ọrịa, gụnyere akpụ agwa.

Pụtara "Atọ-regolith". ngwa

Ọgwụ na-owụt dị ka a ogwu, nakwa dị ka imebi nke ịhụ nsọ okirikiri nke a ọtọ ọdịdị (dysmenorrhea enweghị organic akpata, premenstrual syndrome, dysfunctional metrorrhagia gụnyere).

Contraindications ojiji nke ọgwụ "Atọ-regolith" ntụziaka ndị congenital hyperbilirubinemia, imeju bara ma ọ bụ ozizi, onye ekweghị ibe nọrọ. Ọ bụghị prescribers na cerebrovascular na obi pathologies oké nkebi, predisposing ka thromboembolism na ya nnweta, hemorrhagic ma ọ bụ ischemic ọrịa strok, decompensated obi ọdịda-adịghị ala ala na-adọ, myocarditis, atherosclerosis, ọbara mgbali oké iche-iche, obi ntụpọ. Ọgwụ "Atọ-regolith" ntụziaka anaghị ekwe maka nhọpụta nke-arịa ọrịa shuga mellitus mgbagwoju anya na microangiopathy na retinopathy, anaemia (hemolytic ma ọ bụ ala ala sickle cell). Ọ bụghị na-atụ aro usọbọ maka otosclerosis na mebiri auditory ọrụ, congenital hyperlipidemia. Ekwela idepụta ọgwụ na ọrịa ndị na-na-enwe oké nchegbu na na akwara ụda olu (nkụzi, ọkà okwu). Contraindications gụnyere afọ karịrị afọ iri anọ, Marfan syndrome.

Akpan akpan ịkpachara anya ga-gosipụtara mgbe eji ọgwụ "Atọ-regolith" ọrịa na ịda mbà n'obi, ọdịdọ ọrịa, ọrịa nke gallbladder na imeju na. Ọ dị mkpa ka ịhazie dose n'ihi na ndị inyom na ọrịa nke akụrụ, ụkwara nta, mastopathy, eriri akpa nwa myoma, ọnyá afọ. Akpan akpan ịkpachara anya ga-gosipụtara mgbe anamde ibọ ọgwụ ọrịa na-eto eto na oge ufodu ovulation cycles.

Ọgwụ "Atọ-regolith" nwere ike ime ka ọrịa uche na libido, anyịnwa ịhụkwu nke olu, ibu ibu, isi ọwụwa, vomiting. Mgbe anata ọgwụ engorgement-e kwuru na mammary glands, omume nke intermenstrual secretions, visual n'ọgba aghara, conjunctivitis, ọzịza nke eyelids. Ruo ogologo oge iji ọgwụ nwere ike ime ka ikpe ọnwụ, jaundice, generalized itching, cramps na nwa ehi akwara. Na obere okwu, hypertriglyceridemia nwere ike ubara ọbara mgbali. Site adịkarịghị aa oghom Jeremaya mere gụnyere afọ ọsịsa, ike ọgwụgwụ, mmamiri candidiasis, ọkụ ọkụ na akpụkpọ.

Malite na ọgwụ kwesịrị mbụ (dabere na ụdị media: 2, 3 ma ọ bụ monophasic) ma ọ bụ ise nke okirikiri. Ọnụọgụ ọgwụ - otu mbadamba a ụbọchị. The N'ezie - iri abụọ na otu ụbọchị sochiri a ụbọchị asaa ezumike.

Tupu ewere a ọgwụ, "Atọ-regolith" ịchọ na a ọkachamara.